BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23163687)

  • 1. Non-melanoma skin cancer in Australia.
    Fransen M; Karahalios A; Sharma N; English DR; Giles GG; Sinclair RD
    Med J Aust; 2012 Nov; 197(10):565-8. PubMed ID: 23163687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost for the treatment of actinic keratosis on the rise in Australia.
    Perera E; McGuigan S; Sinclair R
    F1000Res; 2014; 3():184. PubMed ID: 25309734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-melanoma skin cancers in New Zealand--a neglected problem.
    Brougham ND; Dennett ER; Tan ST
    N Z Med J; 2010 Nov; 123(1325):59-65. PubMed ID: 21317962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economic evaluation of non-melanoma skin cancer and actinic keratosis.
    Higashi MK; Veenstra DL; Langley PC
    Pharmacoeconomics; 2004; 22(2):83-94. PubMed ID: 14731050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma skin cancer: an episode of care management approach.
    Housman TS; Williford PM; Feldman SR; Teuschler HV; Fleischer AB; Goldman ND; Balkrishnan R; Chen GJ
    Dermatol Surg; 2003 Jul; 29(7):700-11. PubMed ID: 12828693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
    Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
    J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.
    Elliott TM; Whiteman DC; Olsen CM; Gordon LG
    Appl Health Econ Health Policy; 2017 Dec; 15(6):805-816. PubMed ID: 28756584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and cost of nonmelanoma skin cancer management.
    John Chen G; Yelverton CB; Polisetty SS; Housman TS; Williford PM; Teuschler HV; Feldman SR
    Dermatol Surg; 2006 Oct; 32(10):1266-71. PubMed ID: 17034377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic impact of non-melanoma skin cancer: a review.
    Mudigonda T; Pearce DJ; Yentzer BA; Williford P; Feldman SR
    J Natl Compr Canc Netw; 2010 Aug; 8(8):888-96. PubMed ID: 20870635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
    Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data.
    Tran DA; Coronado AC; Sarker S; Alvi R
    Curr Oncol; 2019 Apr; 26(2):114-118. PubMed ID: 31043813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review.
    Perera E; Gnaneswaran N; Staines C; Win AK; Sinclair R
    Australas J Dermatol; 2015 Nov; 56(4):258-67. PubMed ID: 25716064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare.
    Joseph AK; Mark TL; Mueller C
    Dermatol Surg; 2001 Nov; 27(11):955-9. PubMed ID: 11737130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of nonmelanoma skin cancer treatment in the United States.
    Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
    Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin cancer healthcare impact: A nation-wide assessment of an administrative database.
    Duarte AF; Sousa-Pinto B; Freitas A; Delgado L; Costa-Pereira A; Correia O
    Cancer Epidemiol; 2018 Oct; 56():154-160. PubMed ID: 30179829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the healthcare costs of skin cancer in South Africa.
    Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W
    BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and economic burden of nonmelanoma skin cancer.
    Cakir BÖ; Adamson P; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
    Stern RS
    Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No end in sight: the skin cancer epidemic continues.
    Donaldson MR; Coldiron BM
    Semin Cutan Med Surg; 2011 Mar; 30(1):3-5. PubMed ID: 21540015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.